Specific immunotherapy for allergic rhinitis in Italy

The doctors' points of view

M. Larosa, G. Ciprandi, C. F. Tesi, G. Cadario, A. Fiocchi, F. Frati, A. Romano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its prescription is quite restricted. A perspective and cross-sectional survey based on telephone interviews was carried out in Italy to evaluate the profile of doctors prescribing SIT for allergic rhinitis. A total of 540 doctors were interviewed, 200 of whom are GPs, 60 allergists, 60 ENT specialists, 100 familial paediatricians, 60 hospital paediatricians and 60 pulmonologists. Significant differences concern diagnostic and therapeutic management of allergic rhinitis, mainly regarding SIT prescription. The allergist is the most important consultant who prescribes SIT, as opposed to the paediatrician. This study therefore provides the evidence that doctors' behaviour towards SIT depends on the type of graduate studies.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalInternational Journal of Immunopathology and Pharmacology
Volume22
Issue number1
Publication statusPublished - Jan 2009

Fingerprint

Immunotherapy
Italy
Prescriptions
Consultants
Hypersensitivity
Cross-Sectional Studies
Allergic Rhinitis
Interviews
Therapeutics
Pediatricians
Allergists

Keywords

  • Allergic rhinitis
  • Doctors
  • Educational level
  • Perscription
  • Specific immunotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Specific immunotherapy for allergic rhinitis in Italy : The doctors' points of view. / Larosa, M.; Ciprandi, G.; Tesi, C. F.; Cadario, G.; Fiocchi, A.; Frati, F.; Romano, A.

In: International Journal of Immunopathology and Pharmacology, Vol. 22, No. 1, 01.2009, p. 251-254.

Research output: Contribution to journalArticle

@article{877b64d4bf69402398f494b3bdaf42fc,
title = "Specific immunotherapy for allergic rhinitis in Italy: The doctors' points of view",
abstract = "Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its prescription is quite restricted. A perspective and cross-sectional survey based on telephone interviews was carried out in Italy to evaluate the profile of doctors prescribing SIT for allergic rhinitis. A total of 540 doctors were interviewed, 200 of whom are GPs, 60 allergists, 60 ENT specialists, 100 familial paediatricians, 60 hospital paediatricians and 60 pulmonologists. Significant differences concern diagnostic and therapeutic management of allergic rhinitis, mainly regarding SIT prescription. The allergist is the most important consultant who prescribes SIT, as opposed to the paediatrician. This study therefore provides the evidence that doctors' behaviour towards SIT depends on the type of graduate studies.",
keywords = "Allergic rhinitis, Doctors, Educational level, Perscription, Specific immunotherapy",
author = "M. Larosa and G. Ciprandi and Tesi, {C. F.} and G. Cadario and A. Fiocchi and F. Frati and A. Romano",
year = "2009",
month = "1",
language = "English",
volume = "22",
pages = "251--254",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "1",

}

TY - JOUR

T1 - Specific immunotherapy for allergic rhinitis in Italy

T2 - The doctors' points of view

AU - Larosa, M.

AU - Ciprandi, G.

AU - Tesi, C. F.

AU - Cadario, G.

AU - Fiocchi, A.

AU - Frati, F.

AU - Romano, A.

PY - 2009/1

Y1 - 2009/1

N2 - Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its prescription is quite restricted. A perspective and cross-sectional survey based on telephone interviews was carried out in Italy to evaluate the profile of doctors prescribing SIT for allergic rhinitis. A total of 540 doctors were interviewed, 200 of whom are GPs, 60 allergists, 60 ENT specialists, 100 familial paediatricians, 60 hospital paediatricians and 60 pulmonologists. Significant differences concern diagnostic and therapeutic management of allergic rhinitis, mainly regarding SIT prescription. The allergist is the most important consultant who prescribes SIT, as opposed to the paediatrician. This study therefore provides the evidence that doctors' behaviour towards SIT depends on the type of graduate studies.

AB - Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its prescription is quite restricted. A perspective and cross-sectional survey based on telephone interviews was carried out in Italy to evaluate the profile of doctors prescribing SIT for allergic rhinitis. A total of 540 doctors were interviewed, 200 of whom are GPs, 60 allergists, 60 ENT specialists, 100 familial paediatricians, 60 hospital paediatricians and 60 pulmonologists. Significant differences concern diagnostic and therapeutic management of allergic rhinitis, mainly regarding SIT prescription. The allergist is the most important consultant who prescribes SIT, as opposed to the paediatrician. This study therefore provides the evidence that doctors' behaviour towards SIT depends on the type of graduate studies.

KW - Allergic rhinitis

KW - Doctors

KW - Educational level

KW - Perscription

KW - Specific immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=62649121987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649121987&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 251

EP - 254

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 1

ER -